Recently, the same group of researchers investigated the effect of IGF1 on NASH and cirrhotic mice models and demonstrated that IGF1 ameliorated steatosis, inflammation, and fibrosis. The gene discussed is IGF1; the disease is metabolic dysfunction-associated steatohepatitis.